Name and surname:
|
prof. MUDr. Ján Murín, CSc.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
University teacher - assistant | Comenius University in Bratislava, Medical faculty | 1976 - 1980 |
University teacher - assistant professor | Comenius University in Bratislava, Medical faculty | 1980 - 1993 |
Associate Professor | Comenius University in Bratislava, Medical faculty | 1993 - 2000 |
Professor | Comenius University in Bratislava, Medical faculty | 2000 - until now |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Certificate in internal medicine, second degree | Comenius University in Bratislava, Medical faculty | 1980 |
Certificate in cardiology | Comenius University in Bratislava, Medical faculty | 1986 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Internal medicine | General medicine | II. | General medicine |
Diploma Thesis | General medicine | II. | General medicine |
Valentová M, von Haehling S, Bauditz J ...Murín J et al. Intestinal congestion and right ventricular dysfunction:a link with appetite loss, inflammation, and cachexia in chronic heart failure. In: Eur Heart J 2016;37(21):1684-1691 (IF 19.651)
Wawruch M, Murin J, Tesar T et al. Adherence to antiplatelet medications among persistent and non-persistent older patients with peripheral arterial disease. In: Biomedicines 2021;9(12):1-11(IF 4.757)
Wawruch M, Wimmer G, Murin J et al Patient associated characteristics influencing the risk for non-persistence with statins in older patients with peripheral arterial disease. In: Drugs and Aging 2019;36(9):863-873 (IF 2.824)
Gamra H, Murin J, Chiang Chern-En et al. In: Archives of Cardiovascular Disease 2014;107(2):77-87 (IF 1.840)
Ridker PM, Revkin J, Amarenco P …Murin J. Cardiovascular efficacy and safety of bococizumab in high-risk patients. In: N Engl J Med 2017;376(16):1527-1539 (IF 79.258)
Wawruch M, Murin J, Tesar T et al. Non-persistence with antiplatelet medications among older patients with peripjheral arteraial disease. In: Frontiers in Pharmacologz 2021;12(5):1-9 (IF 5.988)
Schwartz GG, Steg PhG, Szarek M …Murin J… Alirocumab and cardiovascular outcomes after acute coronary syndrome. In:N Engl J Med 2018;379(22):2097-2107
Fudim M, White J, Pagidipati NJ …Murin J.. Effects of once-weekly exenatide in patients with type 2 diabetes mellitus with and without heart failure and heart failure-related outcomes: sights from the EXSCEL trial. In: Circulation 2019;140(20):1613-1622 (IF 23.603)
Kapelios ChJ, Lainscak M, Savarese G,… Murin J…Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC Guidelines and real world. In: Eur J Heart Failure 2019;21(11):1383-1397 (IF 11.627)
Ray KK, Colhoun HM, Szarek M …Murin J…Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomized controlled trial In: Lancet Diabetes and Endocrinology 2019;7(8):618-628 (IF 25.340)
VEGA 1/0939/14 Augmentation (augmentation index) of systolic blood pressure and aortic stiffness in the diagnosis and treatment of arterial hypertension and its complications. (responsible project manager)
VEGA 1/0135/09 Peculiarities of pharmacotherapy in geriatrics and the possibility of evaluating its quality (representative of the responsible project manager)
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Scientific secretary of the Slovak Internal Medicine Society | Slovak Internal Medicine Society | 2004 - 2023 |
Chairman of the Slovak Internist Society | Slovak Internal Medicine Society | 2001 - 2005 |
Member of the committee of the Slovak Cardiology Society | Slovak Cardiology Society | 1988 - 2009 |
President of the Slovak Cardiology Society | Slovak Cardiology Society | 2006 - 2009 |
Member of the categorization commission of the Slovak Ministry of Health | Slovak Ministry of Health | 2004 - 2023 |
Chairman of the Commission for Purposeful Pharmacotherapy in the Faculty/University Hospital | Faculty/University Hospital | 1994 - 2023 |
Member of the Ethics Committee at the Faculty/University Hospital | Faculty/University Hospital | 1990 - until now |
Member of the Scientific Council of the Medical Faculty of the Comenius University in Bratislava | Medical Faculty of the Comenius University in Bratislava | 2011 - 2015 |
Member of the Scientific Council of the MF at UPJŠ in Košice | MF at UPJŠ in Košice | 2022 - until now |
Consultant of the Office for Health Care Supervision | Office for Health Care Supervision | 2004 - until now |